Edward Tenthoff

Sr Research Analyst
Sector Expertise
Additional Expertise
Ted Tenthoff is a managing director and senior research analyst at Piper Sandler, focused on the drug discovery sector of the biotech industry. In April 2013 and 2015, Tenthoff moderated panels at the International Adult Stem Cell Conference at the Vatican. He was ranked No. 2 stock picker in biotechnology by the 2012 Wall Street Journal "Best on the Street" survey and was ranked No. 1 stock picker for the life science tools and services sector in the 2006 Starmine Analyst Awards. Prior to joining Piper Sandler in 2003, he covered the genomics sector at Robertson Stephens & Company, and was a medical technology analyst at Lehman Brothers. Tenthoff received a bachelor’s degree in international relations from the University of Pennsylvania.

Universe Coverage

ALNYAlnylam Pharmaceuticals, Inc.
ARWRArrowhead Pharmaceuticals
ARVNArvinas Inc.
IPSCCentury Therapeutics, Inc.
CRSPCRISPR Therapeutics AG
CUECue Biopharma, Inc.
DYNDyne Therapeutics, Inc.
FATEFate Therapeutics, Inc.
FULCFulcrum Therapeutics, Inc.
GRTSGritstone bio, Inc.
KRONKronos Bio, Inc.
KYMRKymera Therapeutics, Inc.
LEGNLegend Biotech Corporation
MESOMesoblast Ltd.
MISTMilestone Pharmaceuticals, Inc.
MRNAModerna, Inc.
GLUEMonte Rosa Therapeutics, Inc.
NXTCNextCure, Inc.
OMGAOmega Therapeutics, Inc.
OPKOPKO Health, Inc.
PSTXPoseida Therapeutics, Inc.
RAPTRapt Therapeutics, Inc.
MCRBSeres Therapeutics, Inc.
SKYESkye Bioscience, Inc.
STROSutro Biopharma, Inc.
SYRSSyros Pharmaceuticals, Inc.
TPSTTempest Therapeutics, Inc.
XFORX4 Pharmaceuticals, Inc.
XNCRXencor, Inc.